Spyre Therapeutics (SYRE) Non-cash Items (2015 - 2022)

Spyre Therapeutics (SYRE) has 8 years of Non-cash Items data on file, last reported at $2000.0 in Q4 2022.

• For the quarter ending Q4 2022, Non-cash Items fell 99.39% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2022 stood at $2000.0 (down 99.39% YoY), and the FY2022 full-year result was $2000.0, down 99.39% from the prior year.
• Non-cash Items for Q4 2022 stood at $2000.0, down from $328000.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $4.8 million in Q4 2018 and bottomed at $2000.0 in Q4 2022.
• The 5-year median for Non-cash Items is $3.6 million (2019), against an average of $2.5 million.
• The widest annual swing landed in 2018, when Non-cash Items jumped 93.31%; it then tumbled 99.39% in 2022.
• A 5-year view of Non-cash Items shows it stood at $4.8 million in 2018, then declined by 24.09% to $3.6 million in 2019, then rose by 4.01% to $3.8 million in 2020, then plunged by 91.34% to $328000.0 in 2021, then sank by 99.39% to $2000.0 in 2022.
• The last three Non-cash Items figures came in at $2000.0 (Q4 2022), $328000.0 (Q4 2021), and $3.8 million (Q4 2020), per Business Quant data.

Peer Comparison